Exposure and response prevention (ERP) is the most effective psychological treatment for OCD, with about 50 to 60% of adults who complete treatment achieving clinically significant improvement. For children and adolescents, response rates are even higher, reaching roughly 70% in clinical trials. Those numbers make ERP the gold standard, but they also mean it doesn’t work equally well for everyone, and the details matter.
How Much Symptoms Improve
OCD severity is typically measured on a 40-point scale used in research and clinical settings. A score above 24 is considered severe. In one well-studied intensive ERP program, patients started with an average score of about 26 and dropped to 10 after treatment, a reduction of roughly 60%. A score of 10 falls in the mild range, meaning most participants went from severe OCD to symptoms that no longer dominated their daily lives. That improvement held at four-year follow-up, where the average score stayed at about 10.
For young people, the results are comparable. A large study across 20 community clinics in Scandinavia treated 269 children and teens with a standard 14-session ERP protocol. On average, their OCD symptoms dropped by 53%, and nine out of ten completed the full course of treatment. In clinical trials more broadly, about 60% of young people with OCD reach full remission, meaning they no longer meet diagnostic criteria for the disorder.
How ERP Compares to Medication
When researchers pool data across studies, ERP performs at least as well as, and often better than, standard OCD medications (typically SSRIs or older serotonin-targeting drugs). A meta-analysis published through Mayo Clinic found that ERP as a class was significantly more effective than medications as a class, though some of that advantage disappeared after controlling for differences in how the studies were designed. The practical takeaway: both treatments work, and the choice between them often comes down to whether a trained ERP therapist is available in your area.
Combining the two approaches tends to outperform medication alone. In a study of adolescents, those who received both ERP and an SSRI saw a 44% reduction in symptom severity at 12 weeks, compared to 28% for medication only. The response rate at six weeks was dramatically different: 86% for the combination group versus 26% for medication alone. If you’re already on an SSRI and still struggling, adding ERP is one of the most evidence-supported next steps.
What a Typical Course Looks Like
A standard ERP protocol runs about 20 sessions over roughly 12 to 14 weeks. Sessions involve gradually confronting the situations, thoughts, or objects that trigger your obsessions while resisting the urge to perform compulsions. Early sessions focus on building a hierarchy of fears from least to most distressing, then working through that list at a pace you and your therapist agree on.
Intensive formats also exist. The Bergen 4-day treatment, developed in Norway, compresses ERP into four consecutive days of prolonged exposure, and its outcomes match or exceed those of traditional weekly sessions. Other intensive programs use multi-hour sessions spread over one to three weeks. These concentrated formats can be especially practical for people who can’t commit to months of weekly appointments or who travel for treatment.
Why ERP Works
The older explanation for ERP’s effectiveness was straightforward: if you stay in a feared situation long enough without doing your ritual, your anxiety naturally decreases (habituation), and over time the fear fades. That model has largely been replaced by a more nuanced one. Current thinking holds that ERP doesn’t erase the original fear. Instead, your brain builds a new competing memory that says the feared outcome didn’t happen, or that you can tolerate the distress. This new learning gradually wins out over the old fear association.
This shift in understanding has practical implications. It means the goal of each exposure isn’t necessarily to feel calm by the end of a session. It’s to learn something new: that the feared consequence doesn’t occur, or that you can handle uncertainty better than you expected. Therapists using this approach focus on maximizing surprise and violating your expectations rather than simply waiting for anxiety to drop.
Dropout Rates and Who Doesn’t Respond
One common concern is whether people can actually stick with a treatment that asks them to face their fears head-on. The data is reassuring. A meta-analysis of youth studies found that only about 10% of patients dropped out of ERP, compared to 17% for medication and 21% for other active therapies like relaxation training. When people did leave ERP early, it was usually for logistical reasons (scheduling, transportation) rather than because the treatment felt unbearable. By contrast, dropouts from medication were more often driven by side effects, and dropouts from other therapies were more often due to the treatment not working.
Still, 40 to 50% of adults who complete ERP don’t reach the threshold for “clinically significant improvement.” That doesn’t mean they get nothing from treatment. Many experience partial improvement. But it does mean ERP isn’t a guaranteed fix. Factors that can reduce effectiveness include very severe symptoms at the start, not doing homework exposures between sessions, and the presence of certain co-occurring conditions like severe depression.
How Well Results Last
One of ERP’s strongest selling points is durability. Unlike medication, where symptoms commonly return after stopping the drug, ERP improvements tend to stick. The Bergen program’s follow-up data showed virtually identical symptom scores immediately after treatment and four years later. Studies of children and adolescents show gains holding for at least six to nine months, which is typically as far out as researchers track in controlled trials.
Relapse can happen, particularly during periods of high stress or major life changes. But because ERP teaches a set of skills rather than providing a chemical buffer, people who do experience a return of symptoms often recover more quickly by re-applying the techniques they learned. Some therapists build in booster sessions at planned intervals to reinforce these skills.
Telehealth ERP
Access to trained ERP therapists remains one of the biggest barriers to treatment. Video-based therapy has helped close that gap, and the evidence suggests it works just as well as in-person treatment. A pilot study comparing videoconferencing ERP to intensive inpatient ERP found no significant difference in symptom reduction between the two groups. Both produced large improvements, with patients in the video group actually ending up with slightly lower symptom scores on average, likely because they were practicing exposures in their own homes and real-life environments rather than a clinical setting.
The video-based approach did take longer overall, since inpatient programs pack many sessions into a short stay, while telehealth sessions are spread across weeks. But for people without access to a specialty OCD clinic, remote ERP with a trained therapist is a well-supported alternative to in-person care.